๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Non-pharmacological treatment of depression

โœ Scribed by R. Litta

Publisher
Springer Milan
Year
2006
Tongue
English
Weight
30 KB
Volume
27
Category
Article
ISSN
1590-1874

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Venlafaxine. Pharmacology and therapeuti
Venlafaxine. Pharmacology and therapeutic potential in the treatment of depression
โœ Frances E. Burnett; Timothy G. Dinan ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 158 KB ๐Ÿ‘ 2 views

Venlafaxine is the ยฎrst available antidepressant of the structurally novel SNRI (serotonin noradrenaline-reuptake inhibitor) class of drugs. It resembles the tricyclics in its ability to inhibit presynaptic reuptake of both serotonin and noradrenaline to a clinically signiยฎcant degree. However, it d

Cytokines: abnormalities in major depres
Cytokines: abnormalities in major depression and implications for pharmacological treatment
โœ Sinead M. O'Brien; Lucinda V. Scott; Timothy G. Dinan ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 78 KB

## Abstract The role of cytokines in depression was first considered when the cytokine interferon resulted in โ€˜sickness behaviourโ€™, the symptoms of which are similar to those of major depression. The latter is associated with an increase in proโ€inflammatory cytokines such as interleukinโ€1 (ILโ€1), i